Personalized medicine tailors treatment plans based on the genetic makeup of the patient and the cancer. This approach can significantly reduce the risk of misguided decisions by ensuring that the chosen therapies are most likely to be effective for the individual patient. Techniques such as genomic sequencing and biomarker analysis are integral to this strategy.